Publication | Open Access

Randomized, Phase II Trial of Pemetrexed and Carboplatin with or without Enzastaurin versus Docetaxel and Carboplatin as First-Line Treatment of Patients with Stage IIIB/IV Non-small Cell Lung Cancer

OncologyPhase Ii TrialMedicineClinical TrialsBronchial NeoplasmFirst-line TreatmentPharmacotherapyEnzastaurin Versus DocetaxelCancer TreatmentPharmacologyLung Cancer